IDP-121 Lotion

DRUG4 trials

Sponsors

Valeant Pharmaceuticals, Bausch Health Americas, Inc.

Conditions

AcneAcne Vulgaris

Phase 1

Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

CompletedNCT02849860

Bausch Health Americas, Inc.Acne

Start: 2014-02-28End: 2016-10-31Updated: 2017-12-14

Phase 3

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Valeant PharmaceuticalsAcne Vulgaris

Start: 2015-09-30End: 2016-07-31Target: 800Updated: 2015-09-14

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Valeant PharmaceuticalsAcne Vulgaris

Start: 2015-09-30End: 2016-07-31Target: 800Updated: 2015-09-14

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

CompletedNCT02932306

Bausch Health Americas, Inc.Acne

Start: 2015-11-03End: 2017-02-22Updated: 2020-01-03

Related Papers

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients.

2022-07-14

The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris.

2020-12-012 citations